Department of Medicine and Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
Inflammatory Bowel Disease Outpatients Clinic, Colorectal Surgery Unit, Catholic University of Paraná, Curitiba, Brazil.
Lancet Gastroenterol Hepatol. 2019 Apr;4(4):287-295. doi: 10.1016/S2468-1253(19)30013-5. Epub 2019 Feb 12.
Hospitalisation rates for inflammatory bowel disease (IBD) vary across the world. We aimed to investigate temporal patterns of hospitalisation for IBD in member countries of the Organisation for Economic Co-operation and Development (OECD).
From the OECD database, we assessed IBD-related hospitalisation rates (expressed as annual rates per 100 000 inhabitants) for 34 countries from 1990 to 2016. We calculated mean hospitalisation rates for the period 2010-15 and used joinpoint regression models to calculate average annual percentage changes with 95% CIs.
Mean hospitalisation rates for IBD from 2010 to 2015 were highest in North America (eg, 33·9 per 100 000 in the USA), Europe (eg, 72·9 per 100 000 in Austria), and Oceania (eg, 31·5 per 100 000 in Australia). Hospitalisation rates for IBD were stabilising or decreasing over time in many countries in these regions but increasing in others. Countries in Asia and Latin America and the Caribbean had the lowest IBD-related hospitalisation rates but the greatest increases in rates over time. For example, Turkey had an annual hospitalisation rate of 10·8 per 100 000 inhabitants and an average annual percentage change of 10·4% (95% CI 5·2-15·9). Similarly, Chile had an annual hospitalisation rate of 9·0 per 100 000 inhabitants and an average annual percentage change of 5·9% (4·9-7·0).
Hospitalisation rates for IBD are high in western countries but are typically stabilising or decreasing, whereas rates in many newly industrialised countries are rapidly increasing, which reflects the known increase in IBD prevalence in these countries. Potential explanations for these trends include changes in the epidemiology of IBD, health-care delivery, and infrastructure in these countries, as well as overall country-specific patterns in hospitalisations and differences between countries in data collection methods.
None.
炎症性肠病（IBD）的住院率在全球范围内存在差异。本研究旨在调查经济合作与发展组织（OECD）成员国中 IBD 的住院率随时间变化的情况。
我们从 OECD 数据库中评估了 1990 年至 2016 年 34 个国家的 IBD 相关住院率（以每 10 万人每年的发病率表示）。我们计算了 2010-15 年的平均住院率，并使用 Joinpoint 回归模型计算了具有 95%CI 的平均年百分比变化。
2010-15 年期间，北美（例如，美国为 33.9/10 万人）、欧洲（例如，奥地利为 72.9/10 万人）和大洋洲（例如，澳大利亚为 31.5/10 万人）的 IBD 平均住院率最高。在这些地区的许多国家，IBD 的住院率随着时间的推移趋于稳定或下降，但在其他国家则呈上升趋势。亚洲、拉丁美洲和加勒比地区的国家的 IBD 相关住院率最低，但随着时间的推移住院率增加幅度最大。例如，土耳其的年住院率为 10.8/10 万人，平均年增长率为 10.4%（95%CI 5.2-15.9）。同样，智利的年住院率为 9.0/10 万人，平均年增长率为 5.9%（4.9-7.0）。
西方国家的 IBD 住院率较高，但住院率趋于稳定或下降，而许多新兴工业化国家的住院率迅速上升，这反映了这些国家 IBD 患病率的增加。这些趋势的潜在解释包括这些国家 IBD 流行病学、医疗保健提供和基础设施的变化，以及这些国家特定的住院模式和数据收集方法的国家间差异。
无资金来源。
